Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Danish Cancer Society | OTHER |
| Børnecancerfonden | OTHER |
| Ronald McDonalds Børnefond | OTHER |
| TrygFonden, Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether a modified and resource-oriented form of Guided Imagery and Music (GIM) is effective in reducing side effects of chemotherapy in teenagers with cancer.
(Will be added later)
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Music Group | Experimental | Prescribed medical/chemotherapy treatment plus standard care + Guided Imagery and Music |
|
| Control Group | No Intervention | Prescribed medical/chemotherapy treatment plus standard care |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Guided Imagery and Music | Behavioral | Modified and resource-oriented form of the Bonny Method of Guided Imagery and Music (BM-GIM) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Duration (minutes) of Acute Nausea | Self-reported duration og nausea in minutes during the first 32 hours after onset of chemotherapy | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Measure | Description | Time Frame |
|---|---|---|
| Intensity of Acute Nausea as measured by the Visual Analogue Scale | Self-reported intensity of nausea, calculated as the average of the two measurements | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Distress regarding Acute Nausea as measured by the Visual Analogue Scale |
Not provided
Inclusion Criteria:
Teenagers at the ages 12-17
Four or five (dependent on their overall plan of medical treatment) consecutive courses of chemotherapy administrated at the involved child cancer units and (administered) over a period of minimum 24 hours incl. hydration with assumed moderate to severe nausea and vomiting.
The specific type of chemotherapy may vary across the four/five consecutive courses but shall include one of the following moderate and/or highly emetogenic types of chemotherapy:
Moderate emetogenic chemotherapy:
Highly emetogenic chemotherapy:
Understand Norwegian/Danish
Read Norwegian/Danish (teenagers or alternatively parents)
No significant hearing impairment
Informed written consent (teenagers ≥16 years and parents)
Subsequent verbal confirmation of written informed consent before enrolment in study
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Ilan Sanfi, PhD | Contact | +45 22973661 | ilan@sanfi.dk | |
| Stine Camilla Ærø, BA | Contact | +47 92498316 | sero@ous-hf.no |
| Name | Affiliation | Role |
|---|---|---|
| Ilan Sanfi, PhD | Aarhus University Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Recruiting | Aarhus | 8200 | Denmark |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 34637527 | Derived | Bradt J, Dileo C, Myers-Coffman K, Biondo J. Music interventions for improving psychological and physical outcomes in people with cancer. Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD006911. doi: 10.1002/14651858.CD006911.pub4. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009369 | Neoplasms |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D019018 | Imagery, Psychotherapy |
| D009147 | Music Therapy |
| ID | Term |
|---|---|
| D026441 | Mind-Body Therapies |
| D000529 | Complementary Therapies |
| D013812 | Therapeutics |
| D011613 | Psychotherapy |
Not provided
Not provided
| INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Self-reported distress regarding nausea, calculated as the average of the two measurements |
| Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Amount (mg/m2) of Nausea Reducing Medicine Consumed | During admission (an expected average of 3 days) and the first three days after discharge regarding 5th cycle of chemotherapy after enrolment in study |
| Multiple Acute Side Effects of Chemotherapy as measured by the Memorial Symptom Assessment Scale | Self-reported side effects, calculated as the average of the two measurements. The Memorial Symptom Assessment Scale is a self-report composite measure that measures bodily and psychological symptoms of side effects | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Numbers of Acute Vomiting | Self-reported numbers of vomiting during the first 32 hours | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Duration (minutes) of Acute Pain | Self-reported duration of acute pain in minutes within the first 32 hours after onset of chemotherapy | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Acute Pain Intensity as measured by the Visual Analogue Scale | Self-reported intensity of pain, calculated as the average of the two measurements | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Number of Days to Absolute Neutrophil Count Recovery defined as ANC ≥ 0.5 x 109/L | Number of days before the immune system recovers after chemotherapy. In the study, Absolute Neutrophil Count Recovery (ANCR) is defined as ANCR ≥ 0.5 x 109/L. In addition, if no nadir < 0.5 x 109/L occurs the period is 0 (zero). | Time to Event: Measured Day 1 in 5th cycle of chemotherapy after enrolment in study - until first day with ANC ≥ 0.5 x 109/L after the nadir period (an expected average of 9-15 days) |
| Duration (minutes) of Acute Fatigue | Self-reported duration of acute fatigue in minutes within the first 32 hours after onset of chemotherapy | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Distress regarding Acute Fatigue as measured by a 5-point Likert-type Scale | Self-reported Distress regarding Acute Fatigue, calculated as the average of the two measurements | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Appraised food intake and appetite as measured by a 5-point Likert-type Scale | Self-reported appraised food intake, calculated as the average of the two measurements | Registered the two first evenings within the first 32 hours after onset of chemotherapy during 5th cycle of chemotherapy after enrolment in study |
| Weight (kg) | Change between weight from during course 1 and course 5 after inclusion in study |
| Sense of Coherence as measured by the Antonovsky Sense of Coherence Scale | Self-report, registered once during 5th cycle of chemotherapy | Last day (i.e. expected 3rd or 4th day) of 5th cycle of chemotherapy after enrolment in study |
| Satisfaction with music intervention as measured by a Likert-type Scale (participants in music group only) | Self-report, registered once during 5th cycle of chemotherapy | Last day (i.e. expected 3rd or 4th day) of 5th cycle of chemotherapy after enrolment in study |
| D004191 |
| Behavioral Disciplines and Activities |
| D026421 | Sensory Art Therapies |
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |